{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:29:32Z","timestamp":1792106972793,"version":"4.4.0"},"reference-count":206,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"11","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Commun"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p xml:lang=\"en\">Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi\u2010disciplinary team comprising of experts from all sub\u2010specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence\u2010based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow\u2010up of NPC, which aim to improve the management of NPC.<\/jats:p>","DOI":"10.1002\/cac2.12218","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T14:30:08Z","timestamp":1635258608000},"page":"1195-1227","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":398,"title":["The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma"],"prefix":"10.34133","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-1454","authenticated-orcid":false,"given":"Ling\u2010Long","family":"Tang","sequence":"first","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Pei","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan\u2010Ben","family":"Chen","sequence":"additional","affiliation":[{"name":"Teaching Hospital of Fujian Medical University Provincial Clinical College","place":["Fuzhou, P. R. China"]},{"name":"Cancer Hospital of Fujian Medical University","place":["Fuzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-0902","authenticated-orcid":false,"given":"Ming\u2010Yuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian\u2010Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Cancer Center, West China Hospital","place":["Chengdu, P. R. China"]},{"name":"Sichuan University","place":["Chengdu, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Zhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)","place":["Hangzhou, P. R. China"]},{"name":"Institute of Cancer and Basic Medicine (IBMC)","place":["Hangzhou, P. R. China"]},{"name":"Chinese Academy of Sciences","place":["Hangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Jing","family":"Du","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen\u2010Feng","family":"Fang","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010Sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Feng","sequence":"additional","affiliation":[{"name":"Sichuan Cancer Hospital and Institute","place":["Chengdu, P. R. China"]},{"name":"Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[{"name":"Anhui Provincial Hospital Affiliated to Anhui Medical University","place":["Hefei, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-9048","authenticated-orcid":false,"given":"Fei","family":"Han","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"He","sequence":"additional","affiliation":[{"name":"Affiliated Cancer Hospital of Nanjing Medical University","place":["Nanjing, P. R. China"]},{"name":"Jiangsu Cancer Hospital","place":["Nanjing, P. R. China"]},{"name":"Jiangsu Institute of Cancer Research","place":["Nanjing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao\u2010Su","family":"Hu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De\u2010sheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang\u2010Yuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Tongji Hospital","place":["Wuhan, P. R. China"]},{"name":"Tongji Medical College of Huazhong University of Science and Technology","place":["Wuhan, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Bengbu Medical College","place":["Bengbu, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Guilin Medical University","place":["Guilin, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[{"name":"Zunyi Medical University","place":["Zunyi, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2010Yi","family":"Lang","sequence":"additional","affiliation":[{"name":"Sichuan Cancer Hospital & Institute","place":["Chengdu, P. R. China"]},{"name":"School of Medicine","place":["Chengdu, P. R. China"]},{"name":"University of Electronic Science and Technology of China","place":["Chengdu, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2010Gao","family":"Li","sequence":"additional","affiliation":[{"name":"Jiangxi Cancer Hospital","place":["Nanchang, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-9761","authenticated-orcid":false,"given":"Shao\u2010Jun","family":"Lin","sequence":"additional","affiliation":[{"name":"Teaching Hospital of Fujian Medical University Provincial Clinical College","place":["Fuzhou, P. R. China"]},{"name":"Cancer Hospital of Fujian Medical University","place":["Fuzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu\u2010Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Shaanxi Provincial Cancer Hospital Affiliated to Medical College","place":["Xi'an, P. R. China"]},{"name":"Xi'an Jiaotong University","place":["Xi'an, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[{"name":"First Medical Center of Chinese PLA General Hospital","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-203X","authenticated-orcid":false,"given":"Hai\u2010Qiang","family":"Mai","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2010Yong","family":"Qin","sequence":"additional","affiliation":[{"name":"Yunnan Cancer Hospital","place":["Kunming, P. R. China"]},{"name":"The Third Affiliated Hospital of Kunming Medical University","place":["Kunming, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang\u2010Fang","family":"Shen","sequence":"additional","affiliation":[{"name":"Xiangya Hospital of Central South University","place":["Changsha, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-2929","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei\u2010Guo","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital","place":["Tianjin, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u2010Sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo\u2010Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"The Affiliated Tumor Hospital of Xinjiang Medical University","place":["Urumqi, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Shen","family":"Wang","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center","place":["Shanghai, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital","place":["Chongqing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[{"name":"Affiliated Cancer Hospital of Zhengzhou University","place":["Zhengzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun\u2010Fei","family":"Xia","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao\u2010Wen","family":"Xiao","sequence":"additional","affiliation":[{"name":"Peking University School of Oncology","place":["Beijing, P. R. China"]},{"name":"Beijing Cancer Hospital and Institute","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun\u2010Yu","family":"Yang","sequence":"additional","affiliation":[{"name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-0216","authenticated-orcid":false,"given":"Jun\u2010Lin","family":"Yi","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Dong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Guangxi Medical University Cancer Hospital","place":["Nanning, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Sun Yat\u2010sen University Cancer Center","place":["Guangzhou, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"10022","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua MLK","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet (London, England). 2016;387((10022)):1012\u201024. https:\/\/doi.org\/10.1016\/s0140\u20106736(15)00055\u20100.","journal-title":"Lancet (London, England)"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_2_4_2","article-title":"Global Cancer Observatory: cancer today","author":"Ferlay J","year":"2018","unstructured":"Ferlay J, Ervik M, Lam F, et\u00a0al. Global Cancer Observatory: cancer today. Lyon, France: International Agency for Research on Cancer 2018. https:\/\/gco.iarc.fr\/today (accessed Dec 28, 2018).","journal-title":"Lyon, France: International Agency for Research on Cancer"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30956-0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Tang LL Chen WQ Xue WQ He YQ Zheng RS Zeng YX et\u00a0al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer letters. 2016;374(1):22\u201030. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.040.","DOI":"10.1016\/j.canlet.2016.01.040"},{"key":"e_1_3_2_8_2","volume-title":"AJCC Cancer Staging Manual","author":"Amin MB","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et\u00a0al. AJCC Cancer Staging Manual. 8th ed. New York: Springer, 2017.","edition":"8"},{"issue":"7","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in Combination With Radiotherapy for Definitive\u2010Intent Treatment of Stage II\u2010IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline","volume":"39","author":"Chen YP","year":"2021","unstructured":"Chen YP, Ismaila N, Chua MLK, Colevas AD, Haddad R, Huang SH, et\u00a0al. Chemotherapy in Combination With Radiotherapy for Definitive\u2010Intent Treatment of Stage II\u2010IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2021;39((7)):840\u201059. https:\/\/doi.org\/10.1200\/jco.20.03237.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2019.06.2549","article-title":"The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012","volume":"105","author":"Sun XS","year":"2019","unstructured":"Sun XS, Liu SL, Luo MJ, Li XY, Chen QY, Guo SS, et\u00a0al. The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012. International journal of radiation oncology, biology, physics. 2019;105((3)):581\u201090. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2549.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"5","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.ijrobp.2008.03.017","article-title":"How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography?","volume":"72","author":"Liao XB","year":"2008","unstructured":"Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, et\u00a0al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? International journal of radiation oncology, biology, physics. 2008;72((5)):1368\u201077. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.017.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"11","key":"e_1_3_2_12_2","first-page":"4532","article-title":"Comparison of MRI, CT and 18F\u2010FDG PET\/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies","volume":"8","author":"Chen WS","year":"2016","unstructured":"Chen WS, Li JJ, Hong L, Xing ZB, Wang F, Li CQ. Comparison of MRI, CT and 18F\u2010FDG PET\/CT in the diagnosis of local and metastatic of nasopharyngeal carcinomas: an updated meta analysis of clinical studies. American journal of translational research. 2016;8((11)):4532\u201047.","journal-title":"American journal of translational research"},{"issue":"6","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.oraloncology.2013.05.005","article-title":"Updates on MR imaging and \u00b9\u2078F\u2010FDG PET\/CT imaging in nasopharyngeal carcinoma","volume":"50","author":"Lai V","year":"2014","unstructured":"Lai V, Khong PL. Updates on MR imaging and \u00b9\u2078F\u2010FDG PET\/CT imaging in nasopharyngeal carcinoma. Oral oncology. 2014;50((6)):539\u201048. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.05.005.","journal-title":"Oral oncology"},{"issue":"2","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2004.09.057","article-title":"Nasopharyngeal carcinoma staging by (18)F\u2010fluorodeoxyglucose positron emission tomography","volume":"62","author":"Chang JT","year":"2005","unstructured":"Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Lin KJ, et\u00a0al. Nasopharyngeal carcinoma staging by (18)F\u2010fluorodeoxyglucose positron emission tomography. International journal of radiation oncology, biology, physics. 2005;62((2)):501\u20107. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.09.057.","journal-title":"International journal of radiation oncology"},{"issue":"1","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40880-017-0265-9","article-title":"Significant value of (18)F\u2010FDG\u2010PET\/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity\u2010modulated radiotherapy","volume":"36","author":"Peng H","year":"2017","unstructured":"Peng H, Chen L, Tang LL, Li WF, Mao YP, Guo R, et\u00a0al. Significant value of (18)F\u2010FDG\u2010PET\/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity\u2010modulated radiotherapy. Chinese journal of cancer. 2017;36((1)):95. https:\/\/doi.org\/10.1186\/s40880\u2010017\u20100265\u20109.","journal-title":"Chinese journal of cancer"},{"issue":"2","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cncr.11519","article-title":"18\u2010fluoro\u20102\u2010deoxyglucose positron emission tomography in detecting residual\/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging","volume":"98","author":"Yen RF","year":"2003","unstructured":"Yen RF, Hung RL, Pan MH, Wang YH, Huang KM, Lui LT, et\u00a0al. 18\u2010fluoro\u20102\u2010deoxyglucose positron emission tomography in detecting residual\/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer. 2003;98((2)):283\u20107. https:\/\/doi.org\/10.1002\/cncr.11519.","journal-title":"Cancer"},{"issue":"1","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1148\/radiol.2491071753","article-title":"Detection and restaging of residual and\/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET\/CT","volume":"249","author":"Comoretto M","year":"2008","unstructured":"Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M. Detection and restaging of residual and\/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET\/CT. Radiology. 2008;249((1)):203\u201011. https:\/\/doi.org\/10.1148\/radiol.2491071753.","journal-title":"Radiology"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00119","article-title":"Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines","volume":"10","author":"Zhou GQ","year":"2020","unstructured":"Zhou GQ, Lv JW, Tang LL, Mao YP, Guo R, Ma J, et\u00a0al. Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines. Frontiers in oncology. 2020;10:119. https:\/\/doi.org\/10.3389\/fonc.2020.00119.","journal-title":"Frontiers in oncology"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Chan SC Yeh CH Yen TC Ng SH Chang JT Lin CY et\u00a0al. Clinical utility of simultaneous whole\u2010body (18)F\u2010FDG PET\/MRI as a single\u2010step imaging modality in the staging of primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging. 2018;45(8):1297\u2010308. https:\/\/doi.org\/10.1007\/s00259\u2010018\u20103986\u20103.","DOI":"10.1007\/s00259-018-3986-3"},{"issue":"23","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1200\/JCO.2012.46.0816","article-title":"Prospective study of tailoring whole\u2010body dual\u2010modality [18F]fluorodeoxyglucose positron emission tomography\/computed tomography with plasma Epstein\u2010Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging","volume":"31","author":"Tang LQ","year":"2013","unstructured":"Tang LQ, Chen QY, Fan W, Liu H, Zhang L, Guo L, et\u00a0al. Prospective study of tailoring whole\u2010body dual\u2010modality [18F]fluorodeoxyglucose positron emission tomography\/computed tomography with plasma Epstein\u2010Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013;31((23)):2861\u20109. https:\/\/doi.org\/10.1200\/jco.2012.46.0816.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hed.20974","article-title":"Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma","volume":"31","author":"Chua ML","year":"2009","unstructured":"Chua ML, Ong SC, Wee JT, Ng DC, Gao F, Tan TW, et\u00a0al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head & neck. 2009;31((3)):346\u201054. https:\/\/doi.org\/10.1002\/hed.20974.","journal-title":"Head & neck"},{"key":"e_1_3_2_22_2","first-page":"629","article-title":"The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas","volume":"81","author":"Liang PC","year":"1962","unstructured":"Liang PC, Ch'En CC, Chu CC, Hu YF, Chu HM, Tsung YS. The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas. Chinese medical journal (Peking, China: 1932). 1962;81:629\u201058.","journal-title":"Chinese medical journal (Peking, China: 1932)"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40880-016-0103-5","article-title":"A new prognostic histopathologic classification of nasopharyngeal carcinoma","volume":"35","author":"Wang HY","year":"2016","unstructured":"Wang HY, Chang YL, To KF, Hwang JS, Mai HQ, Feng YF, et\u00a0al. A new prognostic histopathologic classification of nasopharyngeal carcinoma. Chinese journal of cancer. 2016;35:41. https:\/\/doi.org\/10.1186\/s40880\u2010016\u20100103\u20105.","journal-title":"Chinese journal of cancer"},{"issue":"2","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1017\/S0022215116000451","article-title":"Pathological aspects of the assessment of head and neck cancers: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Helliwell TR","year":"2016","unstructured":"Helliwell TR, Giles TE. Pathological aspects of the assessment of head and neck cancers: United Kingdom National Multidisciplinary Guidelines. The Journal of laryngology and otology. 2016;130((S2)):S59\u2010s65. https:\/\/doi.org\/10.1017\/s0022215116000451.","journal-title":"The Journal of laryngology and otology"},{"key":"e_1_3_2_25_2","volume-title":"National Comprehensive Cancer Network. NCCN clinical practice guidelines: head and neck cancers version 3, 2019","year":"2019","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines: head and neck cancers version 3, 2019. Ft. Washington, PA: NCCN, 2019."},{"issue":"10","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","article-title":"Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO\u2010NPC\u2010001) in southern China","volume":"30","author":"Ji MF","year":"2019","unstructured":"Ji MF, Sheng W, Cheng WM, Ng MH, Wu BH, Yu X, et\u00a0al. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO\u2010NPC\u2010001) in southern China. Annals of oncology: official journal of the European Society for Medical Oncology. 2019;30((10)):1630\u20107. https:\/\/doi.org\/10.1093\/annonc\/mdz231.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Chan KCA Woo JKS King A Zee BCY Lam WKJ Chan SL et\u00a0al. Analysis of Plasma Epstein\u2010Barr Virus DNA to Screen for Nasopharyngeal Cancer. The New England journal of medicine. 2017;377(6):513\u201022. https:\/\/doi.org\/10.1056\/NEJMoa1701717.","DOI":"10.1056\/NEJMoa1701717"},{"issue":"4","key":"e_1_3_2_28_2","article-title":"Current State of PCR\u2010Based Epstein\u2010Barr Virus DNA Testing for Nasopharyngeal Cancer","volume":"109","author":"Kim KY","year":"2017","unstructured":"Kim KY, Le QT, Yom SS, Pinsky BA, Bratman SV, Ng RH, et\u00a0al. Current State of PCR\u2010Based Epstein\u2010Barr Virus DNA Testing for Nasopharyngeal Cancer. Journal of the National Cancer Institute. 2017;109((4)). https:\/\/doi.org\/10.1093\/jnci\/djx007.","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32770"},{"issue":"1","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cncr.31741","article-title":"Proposed modifications and incorporation of plasma Epstein\u2010Barr virus DNA improve the TNM staging system for Epstein\u2010Barr virus\u2010related nasopharyngeal carcinoma","volume":"125","author":"Guo R","year":"2019","unstructured":"Guo R, Tang LL, Mao YP, Du XJ, Chen L, Zhang ZC, et\u00a0al. Proposed modifications and incorporation of plasma Epstein\u2010Barr virus DNA improve the TNM staging system for Epstein\u2010Barr virus\u2010related nasopharyngeal carcinoma. Cancer. 2019;125((1)):79\u201089. https:\/\/doi.org\/10.1002\/cncr.31741.","journal-title":"Cancer"},{"issue":"3","key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity\u2010modulated radiotherapy vs. conventional two\u2010dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng G","year":"2012","unstructured":"Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, et\u00a0al. A prospective, randomized study comparing outcomes and toxicities of intensity\u2010modulated radiotherapy vs. conventional two\u2010dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2012;104((3)):286\u201093. https:\/\/doi.org\/10.1016\/j.radonc.2012.08.013.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"31","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity\u2010modulated radiotherapy on salivary gland function in early\u2010stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam MK","year":"2007","unstructured":"Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et\u00a0al. Prospective randomized study of intensity\u2010modulated radiotherapy on salivary gland function in early\u2010stage nasopharyngeal carcinoma patients. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007;25((31)):4873\u20109. https:\/\/doi.org\/10.1200\/jco.2007.11.5501.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity\u2010modulated radiotherapy vs. conventional radiotherapy for early\u2010stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow EH","year":"2006","unstructured":"Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et\u00a0al. Xerostomia and quality of life after intensity\u2010modulated radiotherapy vs. conventional radiotherapy for early\u2010stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. International journal of radiation oncology, biology, physics. 2006;66((4)):981\u201091. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.06.013.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"3","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194733","article-title":"The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity\u2010modulated radiotherapy era: A systematic review and meta\u2010analysis","volume":"13","author":"Liu F","year":"2018","unstructured":"Liu F, Jin T, Liu L, Xiang Z, Yan R, Yang H. The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity\u2010modulated radiotherapy era: A systematic review and meta\u2010analysis. PloS one. 2018;13((3)):e0194733. https:\/\/doi.org\/10.1371\/journal.pone.0194733.","journal-title":"PloS one"},{"issue":"7","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219611","article-title":"The effectiveness of intensity\u2010modulated radiation therapy versus 2D\u2010RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta\u2010analysis","volume":"14","author":"Du T","year":"2019","unstructured":"Du T, Xiao J, Qiu Z, Wu K. The effectiveness of intensity\u2010modulated radiation therapy versus 2D\u2010RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta\u2010analysis. PloS one. 2019;14((7)):e0219611. https:\/\/doi.org\/10.1371\/journal.pone.0219611.","journal-title":"PloS one"},{"issue":"24","key":"e_1_3_2_36_2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015951","article-title":"Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta\u2010analysis","volume":"98","author":"Luo MS","year":"2019","unstructured":"Luo MS, Huang GJ, Liu HB. Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta\u2010analysis. Medicine. 2019;98((24)):e15951. https:\/\/doi.org\/10.1097\/md.0000000000015951.","journal-title":"Medicine"},{"key":"e_1_3_2_37_2","first-page":"E2130","article-title":"Evidence on effectiveness of intensity\u2010modulated radiotherapy versus 2\u2010dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta\u2010analysis and a systematic review of the literature","volume":"38","author":"Co J","year":"2016","unstructured":"Co J, Mejia MB, Dizon JM. Evidence on effectiveness of intensity\u2010modulated radiotherapy versus 2\u2010dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta\u2010analysis and a systematic review of the literature. Head & neck. 2016;38 Suppl 1:E2130\u201042. https:\/\/doi.org\/10.1002\/hed.23977.","journal-title":"Head & neck"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors","volume":"10","author":"McDowell L","year":"2020","unstructured":"McDowell L, Corry J, Ringash J, Rischin D. Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors. Frontiers in oncology. 2020;10:930. https:\/\/doi.org\/10.3389\/fonc.2020.00930.","journal-title":"Frontiers in oncology"},{"issue":"4","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al\u2010Sarraf M","year":"1998","unstructured":"Al\u2010Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et\u00a0al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1998;16((4)):1310\u20107. https:\/\/doi.org\/10.1200\/jco.1998.16.4.1310.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"22","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity\u2010modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee N","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et\u00a0al. Intensity\u2010modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27((22)):3684\u201090. https:\/\/doi.org\/10.1200\/jco.2008.19.9109.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7150\/jca.17957","article-title":"Magnetic Resonance Imaging\u2010Detected Tumor Residue after Intensity\u2010Modulated Radiation Therapy and its Association with Post\u2010Radiation Plasma Epstein\u2010Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma","volume":"8","author":"Lv JW","year":"2017","unstructured":"Lv JW, Zhou GQ, Li JX, Tang LL, Mao YP, Lin AH, et\u00a0al. Magnetic Resonance Imaging\u2010Detected Tumor Residue after Intensity\u2010Modulated Radiation Therapy and its Association with Post\u2010Radiation Plasma Epstein\u2010Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma. Journal of Cancer. 2017;8((5)):861\u20109. https:\/\/doi.org\/10.7150\/jca.17957.","journal-title":"Journal of Cancer"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13014-015-0401-0","article-title":"A retrospective study of the prognostic value of MRI\u2010derived residual tumors at the end of intensity\u2010modulated radiotherapy in 358 patients with locally\u2010advanced nasopharyngeal carcinoma","volume":"10","author":"He Y","year":"2015","unstructured":"He Y, Zhou Q, Shen L, Zhao Y, Lei M, Wei R, et\u00a0al. A retrospective study of the prognostic value of MRI\u2010derived residual tumors at the end of intensity\u2010modulated radiotherapy in 358 patients with locally\u2010advanced nasopharyngeal carcinoma. Radiation oncology (London, England). 2015;10:89. https:\/\/doi.org\/10.1186\/s13014\u2010015\u20100401\u20100.","journal-title":"Radiation oncology (London, England)"},{"issue":"16","key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/cncr.32972","article-title":"NPC\u20100501 trial on the value of changing chemoradiotherapy sequence, replacing 5\u2010fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma","volume":"126","author":"Lee AWM","year":"2020","unstructured":"Lee AWM, Ngan RKC, Ng WT, Tung SY, Cheng AAC, Kwong DLW, et\u00a0al. NPC\u20100501 trial on the value of changing chemoradiotherapy sequence, replacing 5\u2010fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma. Cancer. 2020;126((16)):3674\u201088. https:\/\/doi.org\/10.1002\/cncr.32972.","journal-title":"Cancer"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","unstructured":"Leech M Coffey M Mast M Moura F Osztavics A Pasini D et\u00a0al. ESTRO ACROP guidelines for positioning immobilisation and position verification of head and neck patients for radiation therapists. Technical innovations & patient support in radiation oncology. 2017;1:1\u20107. https:\/\/doi.org\/10.1016\/j.tipsro.2016.12.001.","DOI":"10.1016\/j.tipsro.2016.12.001"},{"issue":"2","key":"e_1_3_2_45_2","first-page":"196","article-title":"The research of accuracy immobilized using individualized polyurethane scaling agent compared to positioning foam with standard plastics pillow in the radiotherapy of nasopharyngeal carcinoma","volume":"24","author":"Xu S","year":"2015","unstructured":"Xu S, Yao W, Hu J, He H, Zhang H, Chen C, et\u00a0al. The research of accuracy immobilized using individualized polyurethane scaling agent compared to positioning foam with standard plastics pillow in the radiotherapy of nasopharyngeal carcinoma. Chin J Radiat Oncol. 2015,24((2)):196\u20109. https:\/\/doi.org\/10.3760\/cma.j.issn.1004\u20104221.2015.02.022. [in Chinese].","journal-title":"Chin J Radiat Oncol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","unstructured":"Lin CG Xu SK Yao WY Wu YQ Fang JL Wu VWC. Comparison of set up accuracy among three common immobilisation systems for intensity modulated radiotherapy of nasopharyngeal carcinoma patients. Journal of medical radiation sciences. 2017;64(2):106\u201013. https:\/\/doi.org\/10.1002\/jmrs.189.","DOI":"10.1002\/jmrs.189"},{"issue":"6","key":"e_1_3_2_47_2","first-page":"528","article-title":"Setup errors in the applications of two immbolization techniques in neck irradiation","volume":"32","author":"Xu SK","year":"2019","unstructured":"Xu SK, Yao WY, Yan HL, Chen PF, Chen XG, He HL, et\u00a0al. Setup errors in the applications of two immbolization techniques in neck irradiation. J Cancer Control Treat. 2019;32((6)):528\u201032. https:\/\/doi.org\/10.3969\/j.issn.1674\u20100904.2019.06.010. [in Chinese].","journal-title":"J Cancer Control Treat"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1259\/bjr\/17748030","article-title":"Localization: conventional and CT simulation","author":"Baker GR","year":"2006","unstructured":"Baker GR. Localization: conventional and CT simulation. The British journal of radiology. 2006;79 Spec No 1:S36\u201049. https:\/\/doi.org\/10.1259\/bjr\/17748030.","journal-title":"The British journal of radiology"},{"issue":"3","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1120\/jacmp.v17i3.6088","article-title":"Riis \u00d8stergaard L. Comparison of manual and automatic MR\u2010CT registration for radiotherapy of prostate cancer","volume":"17","author":"Korsager AS","year":"2016","unstructured":"Korsager AS, Carl J, Riis \u00d8stergaard L. Comparison of manual and automatic MR\u2010CT registration for radiotherapy of prostate cancer. Journal of applied clinical medical physics. 2016;17((3)):294\u2010303. https:\/\/doi.org\/10.1120\/jacmp.v17i3.6088.","journal-title":"Journal of applied clinical medical physics"},{"issue":"1","key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0360-3016(94)00412-E","article-title":"A customized head and neck support system","volume":"32","author":"Bentel GC","year":"1995","unstructured":"Bentel GC, Marks LB, Sherouse GW, Spencer DP. A customized head and neck support system. International journal of radiation oncology, biology, physics. 1995;32((1)):245\u20108. https:\/\/doi.org\/10.1016\/0360\u20103016(94)00412\u2010e.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","unstructured":"Houweling AC van der Meer S van der Wal E Terhaard CH Raaijmakers CP. Improved immobilization using an individual head support in head and neck cancer patients. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2010;96(1):100\u20103. https:\/\/doi.org\/10.1016\/j.radonc.2010.04.014.","DOI":"10.1016\/j.radonc.2010.04.014"},{"issue":"2","key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(00)00585-X","article-title":"Comparison of treatment plans involving intensity\u2010modulated radiotherapy for nasopharyngeal carcinoma","volume":"48","author":"Xia P","year":"2000","unstructured":"Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity\u2010modulated radiotherapy for nasopharyngeal carcinoma. International journal of radiation oncology, biology, physics. 2000;48((2)):329\u201037. https:\/\/doi.org\/10.1016\/s0360\u20103016(00)00585\u2010x.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"3","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long\u2010term outcomes of intensity\u2010modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun X","year":"2014","unstructured":"Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, et\u00a0al. Long\u2010term outcomes of intensity\u2010modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2014;110((3)):398\u2010403. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.020.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"1","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2008.12.033","article-title":"Volumetric intensity\u2010modulated arc therapy vs. conventional IMRT in head\u2010and\u2010neck cancer: a comparative planning and dosimetric study","volume":"74","author":"Verbakel WF","year":"2009","unstructured":"Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity\u2010modulated arc therapy vs. conventional IMRT in head\u2010and\u2010neck cancer: a comparative planning and dosimetric study. International journal of radiation oncology, biology, physics. 2009;74((1)):252\u20109. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.033.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"3","key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.radonc.2011.11.017","article-title":"Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step\u2010and\u2010shoot IMRT","volume":"104","author":"Lu SH","year":"2012","unstructured":"Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, et\u00a0al. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step\u2010and\u2010shoot IMRT. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2012;104((3)):324\u201030. https:\/\/doi.org\/10.1016\/j.radonc.2011.11.017.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"2","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ijc.1004","article-title":"Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma","volume":"96","author":"Cheng JC","year":"2001","unstructured":"Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. International journal of cancer. 2001;96((2)):126\u201031. https:\/\/doi.org\/10.1002\/ijc.1004.","journal-title":"International journal of cancer"},{"issue":"1","key":"e_1_3_2_57_2","first-page":"110","article-title":"Calibration of CT values used for radiation treatment planning and its impact factors","volume":"25","author":"Qi ZY","year":"2006","unstructured":"Qi ZY, Huang SM, Deng XW. [Calibration of CT values used for radiation treatment planning and its impact factors]. Ai zheng = Aizheng = Chinese journal of cancer. 2006;25((1)):110\u20104.","journal-title":"Ai zheng = Aizheng = Chinese journal of cancer"},{"issue":"6","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","DOI":"10.1118\/1.4876299","article-title":"Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176","volume":"41","author":"Olch AJ","year":"2014","unstructured":"Olch AJ, Gerig L, Li H, Mihaylov I, Morgan A. Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176. Medical physics. 2014;41((6)):061501. https:\/\/doi.org\/10.1118\/1.4876299.","journal-title":"Medical physics"},{"issue":"2","key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1118\/1.1843354","article-title":"A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization","volume":"32","author":"Dempsey JF","year":"2005","unstructured":"Dempsey JF, Romeijn HE, Li JG, Low DA, Palta JR. A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization. Medical physics. 2005;32((2)):380\u20108. https:\/\/doi.org\/10.1118\/1.1843354.","journal-title":"Medical physics"},{"issue":"903","key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1259\/bjr\/42085182","article-title":"Commissioning and quality assurance of the Pinnacle(3) radiotherapy treatment planning system for external beam photons","volume":"76","author":"Bedford JL","year":"2003","unstructured":"Bedford JL, Childs PJ, Nordmark Hansen V, Mosleh\u2010Shirazi MA, Verhaegen F, Warrington AP. Commissioning and quality assurance of the Pinnacle(3) radiotherapy treatment planning system for external beam photons. The British journal of radiology. 2003;76((903)):163\u201076. https:\/\/doi.org\/10.1259\/bjr\/42085182.","journal-title":"The British journal of radiology"},{"issue":"19","key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1088\/0031-9155\/51\/19\/008","article-title":"Dose variations with varying calculation grid size in head and neck IMRT","volume":"51","author":"Chung H","year":"2006","unstructured":"Chung H, Jin H, Palta J, Suh TS, Kim S. Dose variations with varying calculation grid size in head and neck IMRT. Physics in medicine and biology. 2006;51((19)):4841\u201056. https:\/\/doi.org\/10.1088\/0031\u20109155\/51\/19\/008.","journal-title":"Physics in medicine and biology"},{"issue":"13","key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1088\/0031-9155\/52\/13\/002","article-title":"Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases","volume":"52","author":"Hasenbalg F","year":"2007","unstructured":"Hasenbalg F, Neuenschwander H, Mini R, Born EJ. Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases. Physics in medicine and biology. 2007;52((13)):3679\u201091. https:\/\/doi.org\/10.1088\/0031\u20109155\/52\/13\/002.","journal-title":"Physics in medicine and biology"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2020.06.049","article-title":"Magnetic resonance\u2010based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning","volume":"150","author":"Peng Y","year":"2020","unstructured":"Peng Y, Chen S, Qin A, Chen M, Gao X, Liu Y, et\u00a0al. Magnetic resonance\u2010based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2020;150:217\u201024. https:\/\/doi.org\/10.1016\/j.radonc.2020.06.049.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"4","key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/mp.14075","article-title":"Multi\u2010sequence MR image\u2010based synthetic CT generation using a generative adversarial network for head and neck MRI\u2010only radiotherapy","volume":"47","author":"Qi M","year":"2020","unstructured":"Qi M, Li Y, Wu A, Jia Q, Li B, Sun W, et\u00a0al. Multi\u2010sequence MR image\u2010based synthetic CT generation using a generative adversarial network for head and neck MRI\u2010only radiotherapy. Medical physics. 2020;47((4)):1880\u201094. https:\/\/doi.org\/10.1002\/mp.14075.","journal-title":"Medical physics"},{"issue":"9","key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1002\/mp.13663","article-title":"Dosimetric evaluation of synthetic CT for head and neck radiotherapy generated by a patch\u2010based three\u2010dimensional convolutional neural network","volume":"46","author":"Dinkla AM","year":"2019","unstructured":"Dinkla AM, Florkow MC, Maspero M, Savenije MHF, Zijlstra F, Doornaert PAH, et\u00a0al. Dosimetric evaluation of synthetic CT for head and neck radiotherapy generated by a patch\u2010based three\u2010dimensional convolutional neural network. Medical physics. 2019;46((9)):4095\u2010104. https:\/\/doi.org\/10.1002\/mp.13663.","journal-title":"Medical physics"},{"issue":"2","key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mp.13927","article-title":"Patch\u2010based generative adversarial neural network models for head and neck MR\u2010only planning","volume":"47","author":"Klages P","year":"2020","unstructured":"Klages P, Benslimane I, Riyahi S, Jiang J, Hunt M, Deasy JO, et\u00a0al. Patch\u2010based generative adversarial neural network models for head and neck MR\u2010only planning. Medical physics. 2020;47((2)):626\u201042. https:\/\/doi.org\/10.1002\/mp.13927.","journal-title":"Medical physics"},{"issue":"3","key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1118\/1.3514120","article-title":"Dosimetry tools and techniques for IMRT","volume":"38","author":"Low DA","year":"2011","unstructured":"Low DA, Moran JM, Dempsey JF, Dong L, Oldham M. Dosimetry tools and techniques for IMRT. Medical physics. 2011;38((3)):1313\u201038. https:\/\/doi.org\/10.1118\/1.3514120.","journal-title":"Medical physics"},{"issue":"4","key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/mp.12810","article-title":"Tolerance limits and methodologies for IMRT measurement\u2010based verification QA: Recommendations of AAPM Task Group No. 218","volume":"45","author":"Miften M","year":"2018","unstructured":"Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et\u00a0al. Tolerance limits and methodologies for IMRT measurement\u2010based verification QA: Recommendations of AAPM Task Group No. 218. Medical physics. 2018;45((4)):e53\u2010e83. https:\/\/doi.org\/10.1002\/mp.12810.","journal-title":"Medical physics"},{"issue":"3","key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2004.07.696","article-title":"The impact of daily setup variations on head\u2010and\u2010neck intensity\u2010modulated radiation therapy","volume":"61","author":"Hong TS","year":"2005","unstructured":"Hong TS, Tom\u00e9 WA, Chappell RJ, Chinnaiyan P, Mehta MP, Harari PM. The impact of daily setup variations on head\u2010and\u2010neck intensity\u2010modulated radiation therapy. International journal of radiation oncology, biology, physics. 2005;61((3)):779\u201088. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.07.696.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"1","key":"e_1_3_2_70_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-8140(00)00192-4","article-title":"Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy","volume":"56","author":"Xing L","year":"2000","unstructured":"Xing L, Lin Z, Donaldson SS, Le QT, Tate D, Goffinet DR, et\u00a0al. Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2000;56((1)):97\u2010108. https:\/\/doi.org\/10.1016\/s0167\u20108140(00)00192\u20104.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"4","key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijrobp.2007.10.067","article-title":"Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy","volume":"70","author":"Han C","year":"2008","unstructured":"Han C, Chen YJ, Liu A, Schultheiss TE, Wong JY. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. International journal of radiation oncology, biology, physics. 2008;70((4)):1256\u201062. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.10.067.","journal-title":"International journal of radiation oncology"},{"issue":"4","key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2010.07.017","article-title":"Evaluation of the planning target volume in the treatment of head and neck cancer with intensity\u2010modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?","volume":"81","author":"Chen AM","year":"2011","unstructured":"Chen AM, Farwell DG, Luu Q, Donald PJ, Perks J, Purdy JA. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity\u2010modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance? International journal of radiation oncology, biology, physics. 2011;81((4)):943\u20109. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.017.","journal-title":"International journal of radiation oncology"},{"issue":"5","key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ijrobp.2009.03.059","article-title":"Daily image guidance with cone\u2010beam computed tomography for head\u2010and\u2010neck cancer intensity\u2010modulated radiotherapy: a prospective study","volume":"76","author":"Den RB","year":"2010","unstructured":"Den RB, Doemer A, Kubicek G, Bednarz G, Galvin JM, Keane WM, et\u00a0al. Daily image guidance with cone\u2010beam computed tomography for head\u2010and\u2010neck cancer intensity\u2010modulated radiotherapy: a prospective study. International journal of radiation oncology, biology, physics. 2010;76((5)):1353\u20109. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.03.059.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"95","key":"e_1_3_2_74_2","article-title":"Concurrent image\u2010guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma","volume":"6","author":"Shueng PW","year":"2011","unstructured":"Shueng PW, Shen BJ, Wu LJ, Liao LJ, Hsiao CH, Lin YC, et\u00a0al. Concurrent image\u2010guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma. Radiation oncology (London, England). 2011;6:(95). https:\/\/doi.org\/10.1186\/1748\u2010717x\u20106\u201095.","journal-title":"Radiation oncology (London, England)"},{"issue":"1","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijrobp.2011.10.073","article-title":"Do we need daily image\u2010guided radiotherapy by megavoltage computed tomography in head and neck helical tomotherapy? The actual delivered dose to the spinal cord","volume":"84","author":"Duma MN","year":"2012","unstructured":"Duma MN, Kampfer S, Schuster T, Aswathanarayana N, Fromm LS, Molls M, et\u00a0al. Do we need daily image\u2010guided radiotherapy by megavoltage computed tomography in head and neck helical tomotherapy? The actual delivered dose to the spinal cord. International journal of radiation oncology, biology, physics. 2012;84((1)):283\u20108. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.073.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"4","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ijrobp.2015.09.035","article-title":"Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members","volume":"94","author":"Nabavizadeh N","year":"2016","unstructured":"Nabavizadeh N, Elliott DA, Chen Y, Kusano AS, Mitin T, Thomas CR, Jr., et\u00a0al. Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members. International journal of radiation oncology, biology, physics. 2016;94((4)):850\u20107. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.09.035.","journal-title":"International journal of radiation oncology"},{"issue":"2","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2011.08.001","article-title":"Image guidance during head\u2010and\u2010neck cancer radiation therapy: analysis of alignment trends with in\u2010room cone\u2010beam computed tomography scans","volume":"83","author":"Zumsteg Z","year":"2012","unstructured":"Zumsteg Z, DeMarco J, Lee SP, Steinberg ML, Lin CS, McBride W, et\u00a0al. Image guidance during head\u2010and\u2010neck cancer radiation therapy: analysis of alignment trends with in\u2010room cone\u2010beam computed tomography scans. International journal of radiation oncology, biology, physics. 2012;83((2)):712\u20109. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.08.001.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"19","key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.7150\/jca.21582","article-title":"Advantage of PET\/CT in Target Delineation of MRI\u2010negative Cervical Lymph Nodes In Intensity\u2010Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma","volume":"8","author":"Shen G","year":"2017","unstructured":"Shen G, Xiao W, Han F, Fan W, Lin XP, Lu L, et\u00a0al. Advantage of PET\/CT in Target Delineation of MRI\u2010negative Cervical Lymph Nodes In Intensity\u2010Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma. Journal of Cancer. 2017;8((19)):4117\u201023. https:\/\/doi.org\/10.7150\/jca.21582.","journal-title":"Journal of Cancer"},{"key":"e_1_3_2_79_2","doi-asserted-by":"crossref","unstructured":"Yang H Chen X Lin S Rong J Yang M Wen Q et\u00a0al. Treatment outcomes after reduction of the target volume of intensity\u2010modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective multi\u2010center randomized clinical trial. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2018;126(1):37\u201042. https:\/\/doi.org\/10.1016\/j.radonc.2017.07.020.","DOI":"10.1016\/j.radonc.2017.07.020"},{"issue":"4","key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ijrobp.2019.03.043","article-title":"Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10\u2010Year Results of a Phase 2 Study","volume":"104","author":"Zhao C","year":"2019","unstructured":"Zhao C, Miao JJ, Hua YJ, Wang L, Han F, Lu LX, et\u00a0al. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10\u2010Year Results of a Phase 2 Study. International journal of radiation oncology, biology, physics. 2019;104((4)):836\u201044. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.043.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"3","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ijrobp.2008.11.053","article-title":"Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation","volume":"75","author":"Liang SB","year":"2009","unstructured":"Liang SB, Sun Y, Liu LZ, Chen Y, Chen L, Mao YP, et\u00a0al. Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. International journal of radiation oncology, biology, physics. 2009;75((3)):742\u201050. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.11.053.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"4","key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2017.11.004","article-title":"Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines","volume":"100","author":"Lin L","year":"2018","unstructured":"Lin L, Lu Y, Wang XJ, Chen H, Yu S, Tian J, et\u00a0al. Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines. International journal of radiation oncology, biology, physics. 2018;100((4)):891\u2010902. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.004.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","unstructured":"Lee AW Ng WT Pan JJ Poh SS Ahn YC AlHussain H et\u00a0al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2018;126(1):25\u201036. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.032.","DOI":"10.1016\/j.radonc.2017.10.032"},{"key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-015-1669-z","article-title":"Investigation of the feasibility of elective irradiation to neck level Ib using intensity\u2010modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis","volume":"15","author":"Zhang F","year":"2015","unstructured":"Zhang F, Cheng YK, Li WF, Guo R, Chen L, Sun Y, et\u00a0al. Investigation of the feasibility of elective irradiation to neck level Ib using intensity\u2010modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis. BMC cancer. 2015;15:709. https:\/\/doi.org\/10.1186\/s12885\u2010015\u20101669\u2010z.","journal-title":"BMC cancer"},{"issue":"3","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/cncr.24049","article-title":"The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging","volume":"115","author":"Tang L","year":"2009","unstructured":"Tang L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, et\u00a0al. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer. 2009;115((3)):680\u20108. https:\/\/doi.org\/10.1002\/cncr.24049.","journal-title":"Cancer"},{"issue":"4","key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hed.23314","article-title":"Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity\u2010modulated radiotherapy","volume":"36","author":"Chen M","year":"2014","unstructured":"Chen M, Tang LL, Sun Y, Mao YP, Li WF, Guo R, et\u00a0al. Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity\u2010modulated radiotherapy. Head & neck. 2014;36((4)):468\u201073. https:\/\/doi.org\/10.1002\/hed.23314.","journal-title":"Head & neck"},{"issue":"5","key":"e_1_3_2_87_2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijrobp.2009.06.062","article-title":"Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?","volume":"77","author":"Gao Y","year":"2010","unstructured":"Gao Y, Zhu G, Lu J, Ying H, Kong L, Wu Y, et\u00a0al. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? International journal of radiation oncology, biology, physics. 2010;77((5)):1397\u2010402. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.062.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"17","key":"e_1_3_2_88_2","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/cncr.28201","article-title":"A randomized clinical trial comparing prophylactic upper versus whole\u2010neck irradiation in the treatment of patients with node\u2010negative nasopharyngeal carcinoma","volume":"119","author":"Li JG","year":"2013","unstructured":"Li JG, Yuan X, Zhang LL, Tang YQ, Liu L, Chen XD, et\u00a0al. A randomized clinical trial comparing prophylactic upper versus whole\u2010neck irradiation in the treatment of patients with node\u2010negative nasopharyngeal carcinoma. Cancer. 2013;119((17)):3170\u20106. https:\/\/doi.org\/10.1002\/cncr.28201.","journal-title":"Cancer"},{"issue":"1","key":"e_1_3_2_89_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-018-1087-x","article-title":"Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node\u2010negative nasopharyngeal carcinoma: systemic review and meta\u2010analysis of 2, 521 patients","volume":"13","author":"Huang CL","year":"2018","unstructured":"Huang CL, Xu C, Zhang Y, Zhou GQ, Mao YP, Liu Q, et\u00a0al. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node\u2010negative nasopharyngeal carcinoma: systemic review and meta\u2010analysis of 2, 521 patients. Radiation oncology (London, England). 2018;13((1)):141. https:\/\/doi.org\/10.1186\/s13014\u2010018\u20101087\u2010x.","journal-title":"Radiation oncology (London, England)"},{"key":"e_1_3_2_90_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.oraloncology.2017.03.010","article-title":"The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement","volume":"69","author":"Tang LL","year":"2017","unstructured":"Tang LL, Tang XR, Li WF, Chen L, Tian L, Lin AH, et\u00a0al. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement. Oral oncology. 2017;69:68\u201073. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.03.010.","journal-title":"Oral oncology"},{"issue":"6","key":"e_1_3_2_91_2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10147-013-0650-6","article-title":"Sparing level Ib lymph nodes by intensity\u2010modulated radiotherapy in the treatment of nasopharyngeal carcinoma","volume":"19","author":"Chen J","year":"2014","unstructured":"Chen J, Ou D, He X, Hu C. Sparing level Ib lymph nodes by intensity\u2010modulated radiotherapy in the treatment of nasopharyngeal carcinoma. International journal of clinical oncology. 2014;19((6)):998\u20101004. https:\/\/doi.org\/10.1007\/s10147\u2010013\u20100650\u20106.","journal-title":"International journal of clinical oncology"},{"issue":"3","key":"e_1_3_2_92_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiol.2019182012","article-title":"Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma","volume":"291","author":"Lin L","year":"2019","unstructured":"Lin L, Dou Q, Jin YM, Zhou GQ, Tang YQ, Chen WL, et\u00a0al. Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma. Radiology. 2019;291((3)):677\u201086. https:\/\/doi.org\/10.1148\/radiol.2019182012.","journal-title":"Radiology"},{"issue":"3","key":"e_1_3_2_93_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma","volume":"105","author":"Lee AW","year":"2019","unstructured":"Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, et\u00a0al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. International journal of radiation oncology, biology, physics. 2019;105((3)):567\u201080. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2540.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"e_1_3_2_94_2","doi-asserted-by":"crossref","unstructured":"Sun Y Yu XL Luo W Lee AW Wee JT Lee N et\u00a0al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity\u2010modulated radiotherapy. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2014;110(3):390\u20107. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.035.","DOI":"10.1016\/j.radonc.2013.10.035"},{"issue":"4","key":"e_1_3_2_95_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2011.09.054","article-title":"Standardizing naming conventions in radiation oncology","volume":"83","author":"Santanam L","year":"2012","unstructured":"Santanam L, Hurkmans C, Mutic S, van Vliet\u2010Vroegindeweij C, Brame S, Straube W, et\u00a0al. Standardizing naming conventions in radiation oncology. International journal of radiation oncology, biology, physics. 2012;83((4)):1344\u20109. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.054.","journal-title":"International journal of radiation oncology"},{"issue":"3","key":"e_1_3_2_96_2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.radonc.2009.09.013","article-title":"A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique","volume":"93","author":"Wang SZ","year":"2009","unstructured":"Wang SZ, Li J, Miyamoto CT, Chen F, Zhou LF, Zhang HY, et\u00a0al. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2009;93((3)):530\u20103. https:\/\/doi.org\/10.1016\/j.radonc.2009.09.013.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"e_1_3_2_97_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.04.025","article-title":"Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity\u2010modulated radiation therapy for nasopharyngeal carcinoma","volume":"82","author":"Peng YL","year":"2018","unstructured":"Peng YL, Chen L, Shen GZ, Li YN, Yao JJ, Xiao WW, et\u00a0al. Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity\u2010modulated radiation therapy for nasopharyngeal carcinoma. Oral oncology. 2018;82:1\u20107. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.04.025.","journal-title":"Oral oncology"},{"issue":"3","key":"e_1_3_2_98_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.radonc.2015.05.012","article-title":"Multi\u2010subject atlas\u2010based auto\u2010segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi\u2010institution clinical study","volume":"115","author":"Tao CJ","year":"2015","unstructured":"Tao CJ, Yi JL, Chen NY, Ren W, Cheng J, Tung S, et\u00a0al. Multi\u2010subject atlas\u2010based auto\u2010segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi\u2010institution clinical study. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2015;115((3)):407\u201011. https:\/\/doi.org\/10.1016\/j.radonc.2015.05.012.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"e_1_3_2_99_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phro.2020.06.006","article-title":"External validation of deep learning\u2010based contouring of head and neck organs at risk","volume":"15","author":"Brunenberg EJL","year":"2020","unstructured":"Brunenberg EJL, Steinseifer IK, van den Bosch S, Kaanders J, Brouwer CL, Gooding MJ, et\u00a0al. External validation of deep learning\u2010based contouring of head and neck organs at risk. Physics and imaging in radiation oncology. 2020;15:8\u201015. https:\/\/doi.org\/10.1016\/j.phro.2020.06.006.","journal-title":"Physics and imaging in radiation oncology"},{"key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.09.022","article-title":"Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring","volume":"142","author":"van Dijk LV","year":"2020","unstructured":"van Dijk LV, Van den Bosch L, Aljabar P, Peressutti D, Both S, R JHMS, et\u00a0al. Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2020;142:115\u201023. https:\/\/doi.org\/10.1016\/j.radonc.2019.09.022.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"3","key":"e_1_3_2_101_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2019.02.040","article-title":"Deep Learning\u2010Based Delineation of Head and Neck Organs at Risk: Geometric and Dosimetric Evaluation","volume":"104","author":"van Rooij W","year":"2019","unstructured":"van Rooij W, Dahele M, Ribeiro Brandao H, Delaney AR, Slotman BJ, Verbakel WF. Deep Learning\u2010Based Delineation of Head and Neck Organs at Risk: Geometric and Dosimetric Evaluation. International journal of radiation oncology, biology, physics. 2019;104((3)):677\u201084. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.040.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"2","key":"e_1_3_2_102_2","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre LA","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet\u2010Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65((2)):87\u2010108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"e_1_3_2_103_2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial","volume":"103","author":"Chen QY","year":"2011","unstructured":"Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, et\u00a0al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. Journal of the National Cancer Institute. 2011;103((23)):1761\u201070. https:\/\/doi.org\/10.1093\/jnci\/djr432.","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_3_2_104_2","first-page":"24","article-title":"Ten\u2010year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma","volume":"110","author":"Li XY","year":"2019","unstructured":"Li XY, Chen QY, Sun XS, Liu SL, Yan JJ, Guo SS, et\u00a0al. Ten\u2010year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma. European journal of cancer (Oxford, England: 1990). 2019;110:24\u201031. https:\/\/doi.org\/10.1016\/j.ejca.2018.10.020.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"7","key":"e_1_3_2_105_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin\u2010radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan AT","year":"2005","unstructured":"Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, et\u00a0al. Overall survival after concurrent cisplatin\u2010radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute. 2005;97((7)):536\u20109. https:\/\/doi.org\/10.1093\/jnci\/dji084.","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"e_1_3_2_106_2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","article-title":"Concurrent chemotherapy\u2010radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression\u2010free survival analysis of a phase III randomized trial","volume":"20","author":"Chan AT","year":"2002","unstructured":"Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, et\u00a0al. Concurrent chemotherapy\u2010radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression\u2010free survival analysis of a phase III randomized trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2002;20((8)):2038\u201044. https:\/\/doi.org\/10.1200\/jco.2002.08.149.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"e_1_3_2_107_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long\u2010term results of phase 3 randomized controlled trial","volume":"145","author":"Li WF","year":"2019","unstructured":"Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, et\u00a0al. Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long\u2010term results of phase 3 randomized controlled trial. International journal of cancer. 2019;145((1)):295\u2010305. https:\/\/doi.org\/10.1002\/ijc.32099.","journal-title":"International journal of cancer"},{"issue":"11","key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun Y","year":"2016","unstructured":"Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, et\u00a0al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. The Lancet Oncology. 2016;17((11)):1509\u201020. https:\/\/doi.org\/10.1016\/s1470\u20102045(16)30410\u20107.","journal-title":"The Lancet Oncology"},{"key":"e_1_3_2_109_2","doi-asserted-by":"crossref","unstructured":"Zhang Y Chen L Hu GQ Zhang N Zhu XD Yang KY et\u00a0al. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. The New England journal of medicine. 2019;381(12):1124\u201035. https:\/\/doi.org\/10.1056\/NEJMoa1905287.","DOI":"10.1056\/NEJMoa1905287"},{"issue":"2","key":"e_1_3_2_110_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","article-title":"Randomized phase II trial of concurrent cisplatin\u2010radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma","volume":"27","author":"Hui EP","year":"2009","unstructured":"Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, et\u00a0al. Randomized phase II trial of concurrent cisplatin\u2010radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27((2)):242\u20109. https:\/\/doi.org\/10.1200\/jco.2008.18.1545.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"e_1_3_2_111_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long\u2010term results of a phase III multicentre randomised controlled trial","volume":"119","author":"Yang Q","year":"2019","unstructured":"Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, et\u00a0al. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long\u2010term results of a phase III multicentre randomised controlled trial. European journal of cancer (Oxford, England: 1990). 2019;119:87\u201096. https:\/\/doi.org\/10.1016\/j.ejca.2019.07.007.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"27","key":"e_1_3_2_112_2","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety","volume":"23","author":"Wee J","year":"2005","unstructured":"Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, et\u00a0al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005;23((27)):6730\u20108. https:\/\/doi.org\/10.1200\/jco.2005.16.790.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"15","key":"e_1_3_2_113_2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","article-title":"Randomized trial of radiotherapy plus concurrent\u2010adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee AW","year":"2010","unstructured":"Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, et\u00a0al. Randomized trial of radiotherapy plus concurrent\u2010adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute. 2010;102((15)):1188\u201098. https:\/\/doi.org\/10.1093\/jnci\/djq258.","journal-title":"Journal of the National Cancer Institute"},{"issue":"10297","key":"e_1_3_2_114_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(21)01123-5","article-title":"Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open\u2010label, parallel\u2010group, randomised, controlled, phase 3 trial","volume":"398","author":"Chen YP","year":"2021","unstructured":"Chen YP, Liu X, Zhou Q, Yang KY, Jin F, Zhu XD, et\u00a0al. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open\u2010label, parallel\u2010group, randomised, controlled, phase 3 trial. Lancet (London, England). 2021;398((10297)):303\u201013. https:\/\/doi.org\/10.1016\/s0140\u20106736(21)01123\u20105.","journal-title":"Lancet (London, England)"},{"issue":"8","key":"e_1_3_2_115_2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/cncr.29208","article-title":"Preliminary results of trial NPC\u20100501 evaluating the therapeutic gain by changing from concurrent\u2010adjuvant to induction\u2010concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"121","author":"Lee AW","year":"2015","unstructured":"Lee AW, Ngan RK, Tung SY, Cheng A, Kwong DL, Lu TX, et\u00a0al. Preliminary results of trial NPC\u20100501 evaluating the therapeutic gain by changing from concurrent\u2010adjuvant to induction\u2010concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 2015;121((8)):1328\u201038. https:\/\/doi.org\/10.1002\/cncr.29208.","journal-title":"Cancer"},{"issue":"5","key":"e_1_3_2_116_2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cas.13589","article-title":"Anti\u2010epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma","volume":"109","author":"Peng H","year":"2018","unstructured":"Peng H, Tang LL, Liu X, Chen L, Li WF, Mao YP, et\u00a0al. Anti\u2010epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Cancer science. 2018;109((5)):1609\u201016. https:\/\/doi.org\/10.1111\/cas.13589.","journal-title":"Cancer science"},{"key":"e_1_3_2_117_2","doi-asserted-by":"crossref","unstructured":"Tang LQ Chen DP Guo L Mo HY Huang Y Guo SS et\u00a0al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II\u2010IVB nasopharyngeal carcinoma: an open\u2010label non\u2010inferiority randomised phase 3 trial. The Lancet Oncology. 2018;19(4):461\u201073. https:\/\/doi.org\/10.1016\/s1470\u20102045(18)30104\u20109.","DOI":"10.1016\/S1470-2045(18)30104-9"},{"issue":"8","key":"e_1_3_2_118_2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","article-title":"Long\u2010term follow\u2010up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu X","year":"2013","unstructured":"Wu X, Huang PY, Peng PJ, Lu LX, Han F, Wu SX, et\u00a0al. Long\u2010term follow\u2010up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology. 2013;24((8)):2131\u20106. https:\/\/doi.org\/10.1093\/annonc\/mdt163.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"33","key":"e_1_3_2_119_2","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1200\/JCO.2004.00.3863","article-title":"Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results","volume":"23","author":"Zhang L","year":"2005","unstructured":"Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, et\u00a0al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005;23((33)):8461\u20108. https:\/\/doi.org\/10.1200\/jco.2004.00.3863.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"9","key":"e_1_3_2_120_2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ejca.2007.03.022","article-title":"Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non\u2010inferiority, open trial","volume":"43","author":"Chitapanarux I","year":"2007","unstructured":"Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Sumitsawan Y, Tharavichitkul E, Sukthomya V, et\u00a0al. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non\u2010inferiority, open trial. European journal of cancer (Oxford, England: 1990). 2007;43((9)):1399\u2010406. https:\/\/doi.org\/10.1016\/j.ejca.2007.03.022.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"8","key":"e_1_3_2_121_2","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.7150\/thno.19710","article-title":"Concurrent Chemoradiotherapy with or without Anti\u2010EGFR\u2010Targeted Treatment for Stage II\u2010IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow\u2010up","volume":"7","author":"You R","year":"2017","unstructured":"You R, Hua YJ, Liu YP, Yang Q, Zhang YN, Li JB, et\u00a0al. Concurrent Chemoradiotherapy with or without Anti\u2010EGFR\u2010Targeted Treatment for Stage II\u2010IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow\u2010up. Theranostics. 2017;7((8)):2314\u201024. https:\/\/doi.org\/10.7150\/thno.19710.","journal-title":"Theranostics"},{"issue":"6","key":"e_1_3_2_122_2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ijc.30819","article-title":"Cetuximab or nimotuzumab plus intensity\u2010modulated radiotherapy versus cisplatin plus intensity\u2010modulated radiotherapy for stage II\u2010IVb nasopharyngeal carcinoma","volume":"141","author":"You R","year":"2017","unstructured":"You R, Sun R, Hua YJ, Li CF, Li JB, Zou X, et\u00a0al. Cetuximab or nimotuzumab plus intensity\u2010modulated radiotherapy versus cisplatin plus intensity\u2010modulated radiotherapy for stage II\u2010IVb nasopharyngeal carcinoma. International journal of cancer. 2017;141((6)):1265\u201076. https:\/\/doi.org\/10.1002\/ijc.30819.","journal-title":"International journal of cancer"},{"key":"e_1_3_2_123_2","article-title":"Analysis of Plasma Epstein\u2010Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High\u2010Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial","author":"Chan ATC","year":"2018","unstructured":"Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, et\u00a0al. Analysis of Plasma Epstein\u2010Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High\u2010Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018:Jco2018777847. https:\/\/doi.org\/10.1200\/jco.2018.77.7847.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"e_1_3_2_124_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.11.008","article-title":"Prognostic impact of adjuvant chemotherapy in high\u2010risk nasopharyngeal carcinoma patients","volume":"64","author":"Liu YC","year":"2017","unstructured":"Liu YC, Wang WY, Twu CW, Jiang RS, Liang KL, Wu CT, et\u00a0al. Prognostic impact of adjuvant chemotherapy in high\u2010risk nasopharyngeal carcinoma patients. Oral oncology. 2017;64:15\u201021. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.11.008.","journal-title":"Oral oncology"},{"issue":"1","key":"e_1_3_2_125_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13014-019-1387-9","article-title":"Maintenance chemotherapy using S\u20101 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma","volume":"14","author":"Zong J","year":"2019","unstructured":"Zong J, Xu H, Chen B, Guo Q, Xu Y, Chen C, et\u00a0al. Maintenance chemotherapy using S\u20101 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma. Radiation oncology (London, England). 2019;14((1)):182. https:\/\/doi.org\/10.1186\/s13014\u2010019\u20101387\u20109.","journal-title":"Radiation oncology (London, England)"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01314","article-title":"Adding Concurrent Chemotherapy to Intensity\u2010Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial","volume":"10","author":"Huang X","year":"2020","unstructured":"Huang X, Chen X, Zhao C, Wang J, Wang K, Wang L, et\u00a0al. Adding Concurrent Chemotherapy to Intensity\u2010Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial. Frontiers in oncology. 2020;10:1314. https:\/\/doi.org\/10.3389\/fonc.2020.01314.","journal-title":"Frontiers in oncology"},{"key":"e_1_3_2_127_2","doi-asserted-by":"crossref","unstructured":"Blanchard P Lee A Marguet S Leclercq J Ng WT Ma J et\u00a0al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC\u2010NPC meta\u2010analysis. The Lancet Oncology. 2015;16(6):645\u201055. https:\/\/doi.org\/10.1016\/s1470\u20102045(15)70126\u20109.","DOI":"10.1016\/S1470-2045(15)70126-9"},{"key":"e_1_3_2_128_2","unstructured":"Chen L Hu CS Chen XZ Hu GQ Cheng ZB Sun Y et\u00a0al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. The Lancet Oncology. 2012;13(2):163\u201071. https:\/\/doi.org\/10.1016\/s1470\u20102045(11)70320\u20105."},{"key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","article-title":"Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long\u2010term results of a phase 3 multicentre randomised controlled trial","volume":"75","author":"Chen L","year":"2017","unstructured":"Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, et\u00a0al. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long\u2010term results of a phase 3 multicentre randomised controlled trial. European journal of cancer (Oxford, England: 1990). 2017;75:150\u20108. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.002.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"12","key":"e_1_3_2_130_2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2015.04.027","article-title":"Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta\u2010analysis","volume":"51","author":"Yan M","year":"2015","unstructured":"Yan M, Kumachev A, Siu LL, Chan KK. Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta\u2010analysis. European journal of cancer (Oxford, England: 1990). 2015;51((12)):1570\u20109. https:\/\/doi.org\/10.1016\/j.ejca.2015.04.027.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"19","key":"e_1_3_2_131_2","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.7150\/thno.21815","article-title":"The Changing Therapeutic Role of Chemo\u2010radiotherapy for Loco\u2010regionally Advanced Nasopharyngeal Carcinoma from Two\/Three\u2010Dimensional Radiotherapy to Intensity\u2010Modulated Radiotherapy: A Network Meta\u2010Analysis","volume":"7","author":"You R","year":"2017","unstructured":"You R, Cao YS, Huang PY, Chen L, Yang Q, Liu YP, et\u00a0al. The Changing Therapeutic Role of Chemo\u2010radiotherapy for Loco\u2010regionally Advanced Nasopharyngeal Carcinoma from Two\/Three\u2010Dimensional Radiotherapy to Intensity\u2010Modulated Radiotherapy: A Network Meta\u2010Analysis. Theranostics. 2017;7((19)):4825\u201035. https:\/\/doi.org\/10.7150\/thno.21815.","journal-title":"Theranostics"},{"issue":"1","key":"e_1_3_2_132_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/annonc\/mdu507","article-title":"A Bayesian network meta\u2010analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"26","author":"Chen YP","year":"2015","unstructured":"Chen YP, Wang ZX, Chen L, Liu X, Tang LL, Mao YP, et\u00a0al. A Bayesian network meta\u2010analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology. 2015;26((1)):205\u201011. https:\/\/doi.org\/10.1093\/annonc\/mdu507.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"5","key":"e_1_3_2_133_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2016.67.4119","article-title":"What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta\u2010Analysis","volume":"35","author":"Ribassin\u2010Majed L","year":"2017","unstructured":"Ribassin\u2010Majed L, Marguet S, Lee AWM, Ng WT, Ma J, Chan ATC, et\u00a0al. What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta\u2010Analysis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2017;35((5)):498\u2010505. https:\/\/doi.org\/10.1200\/jco.2016.67.4119.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"e_1_3_2_134_2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2007.12.028","article-title":"Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china","volume":"71","author":"Chen Y","year":"2008","unstructured":"Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, et\u00a0al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. International journal of radiation oncology, biology, physics. 2008;71((5)):1356\u201064. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.12.028.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"1","key":"e_1_3_2_135_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2006.03.054","article-title":"Preliminary results of a randomized study (NPC\u20109902 Trial) on therapeutic gain by concurrent chemotherapy and\/or accelerated fractionation for locally advanced nasopharyngeal carcinoma","volume":"66","author":"Lee AW","year":"2006","unstructured":"Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, et\u00a0al. Preliminary results of a randomized study (NPC\u20109902 Trial) on therapeutic gain by concurrent chemotherapy and\/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. International journal of radiation oncology, biology, physics. 2006;66((1)):142\u201051. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.054.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"6","key":"e_1_3_2_136_2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.2005.12.081","article-title":"Long\u2010term survival after cisplatin\u2010based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials","volume":"23","author":"Chua DT","year":"2005","unstructured":"Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et\u00a0al. Long\u2010term survival after cisplatin\u2010based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005;23((6)):1118\u201024. https:\/\/doi.org\/10.1200\/jco.2005.12.081.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"e_1_3_2_137_2","first-page":"14","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial","volume":"75","author":"Cao SM","year":"2017","unstructured":"Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, et\u00a0al. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. European journal of cancer (Oxford, England: 1990). 2017;75:14\u201023. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.039.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"8","key":"e_1_3_2_138_2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-17-2656","article-title":"Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials","volume":"24","author":"Chen YP","year":"2018","unstructured":"Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, et\u00a0al. Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials. Clinical cancer research: an official journal of the American Association for Cancer Research. 2018;24((8)):1824\u201033. https:\/\/doi.org\/10.1158\/1078\u20100432.Ccr\u201017\u20102656.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"3","key":"e_1_3_2_139_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/annonc\/mdx770","article-title":"A randomized trial of induction docetaxel\u2010cisplatin\u20105FU followed by concomitant cisplatin\u2010RT versus concomitant cisplatin\u2010RT in nasopharyngeal carcinoma (GORTEC 2006\u201002)","volume":"29","author":"Frikha M","year":"2018","unstructured":"Frikha M, Auperin A, Tao Y, Elloumi F, Toumi N, Blanchard P, et\u00a0al. A randomized trial of induction docetaxel\u2010cisplatin\u20105FU followed by concomitant cisplatin\u2010RT versus concomitant cisplatin\u2010RT in nasopharyngeal carcinoma (GORTEC 2006\u201002). Annals of oncology: official journal of the European Society for Medical Oncology. 2018;29((3)):731\u20106. https:\/\/doi.org\/10.1093\/annonc\/mdx770.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"2","key":"e_1_3_2_140_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2015.11.030","article-title":"Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG\u2010HN10\u201002)","volume":"118","author":"Lee JY","year":"2016","unstructured":"Lee JY, Sun JM, Oh DR, Lim SH, Goo J, Lee SH, et\u00a0al. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG\u2010HN10\u201002). Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2016;118((2)):244\u201050. https:\/\/doi.org\/10.1016\/j.radonc.2015.11.030.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"e_1_3_2_141_2","doi-asserted-by":"crossref","unstructured":"Liang H Xia W\u2010X Lv X Sun R Zeng Q Li S\u2010W et\u00a0al. Concurrent chemoradiotherapy with 3\u2010weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial (ChiCTR\u2010TRC\u201012001979). 2017;35(15_suppl):6006. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.6006.","DOI":"10.1200\/JCO.2017.35.15_suppl.6006"},{"issue":"5","key":"e_1_3_2_142_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2010.10.026","article-title":"Factors contributing to the efficacy of concurrent\u2010adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC\u20109901 and NPC\u20109902 Trials","volume":"47","author":"Lee AW","year":"2011","unstructured":"Lee AW, Tung SY, Ngan RK, Chappell R, Chua DT, Lu TX, et\u00a0al. Factors contributing to the efficacy of concurrent\u2010adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC\u20109901 and NPC\u20109902 Trials. European journal of cancer (Oxford, England: 1990). 2011;47((5)):656\u201066. https:\/\/doi.org\/10.1016\/j.ejca.2010.10.026.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"11","key":"e_1_3_2_143_2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1634\/theoncologist.2016-0105","article-title":"Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial","volume":"21","author":"Peng H","year":"2016","unstructured":"Peng H, Chen L, Zhang Y, Li WF, Mao YP, Zhang F, et\u00a0al. Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial. The oncologist. 2016;21((11)):1369\u201076. https:\/\/doi.org\/10.1634\/theoncologist.2016\u20100105.","journal-title":"The oncologist"},{"issue":"5","key":"e_1_3_2_144_2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2018.04.069","article-title":"Concurrent\u2010Adjuvant Chemoradiation Therapy for Stage III\u2010IVB Nasopharyngeal Carcinoma\u2010Exploration for Achieving Optimal 10\u2010Year Therapeutic Ratio","volume":"101","author":"Ng WT","year":"2018","unstructured":"Ng WT, Tung SY, Lee V, Ngan RKC, Choi HCW, Chan LLK, et\u00a0al. Concurrent\u2010Adjuvant Chemoradiation Therapy for Stage III\u2010IVB Nasopharyngeal Carcinoma\u2010Exploration for Achieving Optimal 10\u2010Year Therapeutic Ratio. International journal of radiation oncology, biology, physics. 2018;101((5)):1078\u201086. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.069.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"13","key":"e_1_3_2_145_2","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.ejca.2015.05.025","article-title":"Ten\u2010year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single\u2010institution experience from an endemic area","volume":"51","author":"Huang PY","year":"2015","unstructured":"Huang PY, Zeng Q, Cao KJ, Guo X, Guo L, Mo HY, et\u00a0al. Ten\u2010year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single\u2010institution experience from an endemic area. European journal of cancer (Oxford, England: 1990). 2015;51((13)):1760\u201070. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.025.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"1","key":"e_1_3_2_146_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100620","article-title":"Two\u2010year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin\/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial","volume":"45","author":"Chitapanarux I","year":"2021","unstructured":"Chitapanarux I, Kittichest R, Tungkasamit T, Asakit T, Chomprasert K, Chakrabandhu S, et\u00a0al. Two\u2010year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin\/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial. Current problems in cancer. 2021;45((1)):100620. https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100620.","journal-title":"Current problems in cancer"},{"key":"e_1_3_2_147_2","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00302-8","article-title":"Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first\u2010line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN\u20101st): a multicentre, randomised, double\u2010blind, phase 3 trial","author":"Yang Y","year":"2021","unstructured":"Yang Y, Qu S, Li J, Hu C, Xu M, Li W, et\u00a0al. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first\u2010line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN\u20101st): a multicentre, randomised, double\u2010blind, phase 3 trial. The Lancet Oncology. 2021. https:\/\/doi.org\/10.1016\/s1470\u20102045(21)00302\u20108.","journal-title":"The Lancet Oncology"},{"key":"e_1_3_2_148_2","article-title":"Toripalimab or placebo plus chemotherapy as first\u2010line treatment in advanced nasopharyngeal carcinoma: a multi\u2010center randomized phase 3 trial","author":"Mai HQ","year":"2021","unstructured":"Mai HQ, Chen QY, Chen DP, et\u00a0al. Toripalimab or placebo plus chemotherapy as first\u2010line treatment in advanced nasopharyngeal carcinoma: a multi\u2010center randomized phase 3 trial. Nat Med, 2021, Online First.","journal-title":"Nat Med"},{"issue":"10054","key":"e_1_3_2_149_2","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open\u2010label, phase 3 trial","volume":"388","author":"Zhang L","year":"2016","unstructured":"Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, et\u00a0al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open\u2010label, phase 3 trial. Lancet (London, England). 2016;388((10054)):1883\u201092. https:\/\/doi.org\/10.1016\/s0140\u20106736(16)31388\u20105.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"e_1_3_2_150_2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaoncol.2020.1808","article-title":"Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial","volume":"6","author":"You R","year":"2020","unstructured":"You R, Liu YP, Huang PY, Zou X, Sun R, He YX, et\u00a0al. Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA oncology. 2020;6((9)):1345\u201052. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1808.","journal-title":"JAMA oncology"},{"issue":"1","key":"e_1_3_2_151_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.annonc.a058703","article-title":"A phase II trial of 5\u2010fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma","volume":"5","author":"Au E","year":"1994","unstructured":"Au E, Ang PT. A phase II trial of 5\u2010fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology. 1994;5((1)):87\u20109. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058703.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"5","key":"e_1_3_2_152_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s002800050512","article-title":"Phase II study of the combination of carboplatin and 5\u2010fluorouracil in metastatic nasopharyngeal carcinoma","volume":"38","author":"Yeo W","year":"1996","unstructured":"Yeo W, Leung TW, Leung SF, Teo PM, Chan AT, Lee WY, et\u00a0al. Phase II study of the combination of carboplatin and 5\u2010fluorouracil in metastatic nasopharyngeal carcinoma. Cancer chemotherapy and pharmacology. 1996;38((5)):466\u201070. https:\/\/doi.org\/10.1007\/s002800050512.","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"17","key":"e_1_3_2_153_2","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/j.ejca.2012.06.009","article-title":"A prospective multicentre phase II study of cisplatin and weekly docetaxel as first\u2010line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07\u201001)","volume":"48","author":"Ji JH","year":"2012","unstructured":"Ji JH, Yun T, Kim SB, Kang JH, Park JC, Cho IS, et\u00a0al. A prospective multicentre phase II study of cisplatin and weekly docetaxel as first\u2010line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07\u201001). European journal of cancer (Oxford, England: 1990). 2012;48((17)):3198\u2010204. https:\/\/doi.org\/10.1016\/j.ejca.2012.06.009.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"2","key":"e_1_3_2_154_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1008390929826","article-title":"Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma","volume":"10","author":"Tan EH","year":"1999","unstructured":"Tan EH, Khoo KS, Wee J, Fong KW, Lee KS, Lee KM, et\u00a0al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology. 1999;10((2)):235\u20107. https:\/\/doi.org\/10.1023\/a:1008390929826.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"3","key":"e_1_3_2_155_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00280-007-0641-2","article-title":"Phase II study of capecitabine and cisplatin combination as first\u2010line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma","volume":"62","author":"Li YH","year":"2008","unstructured":"Li YH, Wang FH, Jiang WQ, Xiang XJ, Deng YM, Hu GQ, et\u00a0al. Phase II study of capecitabine and cisplatin combination as first\u2010line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma. Cancer chemotherapy and pharmacology. 2008;62((3)):539\u201044. https:\/\/doi.org\/10.1007\/s00280\u2010007\u20100641\u20102.","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"e_1_3_2_156_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-016-2517-5","article-title":"Phase I\/II dose\u2010finding study of nanoparticle albumin\u2010bound paclitaxel (nab\u00ae\u2010Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma","volume":"16","author":"Huang Y","year":"2016","unstructured":"Huang Y, Liang W, Yang Y, Zhao L, Zhao H, Wu X, et\u00a0al. Phase I\/II dose\u2010finding study of nanoparticle albumin\u2010bound paclitaxel (nab\u00ae\u2010Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma. BMC cancer. 2016;16:464. https:\/\/doi.org\/10.1186\/s12885\u2010016\u20102517\u20105.","journal-title":"BMC cancer"},{"issue":"6","key":"e_1_3_2_157_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3727\/096504014X13983417587401","article-title":"A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286)","volume":"21","author":"Jin T","year":"2013","unstructured":"Jin T, Li B, Chen XZ. A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286). Oncology research. 2013;21((6)):317\u201023. https:\/\/doi.org\/10.3727\/096504014x13983417587401.","journal-title":"Oncology research"},{"issue":"4","key":"e_1_3_2_158_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1368-8375(02)00120-3","article-title":"A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum\u2010based chemotherapy","volume":"39","author":"Chua DT","year":"2003","unstructured":"Chua DT, Sham JS, Au GK. A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum\u2010based chemotherapy. Oral oncology. 2003;39((4)):361\u20106. https:\/\/doi.org\/10.1016\/s1368\u20108375(02)00120\u20103.","journal-title":"Oral oncology"},{"issue":"1","key":"e_1_3_2_159_2","first-page":"37","article-title":"Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study","volume":"13","author":"Ciuleanu E","year":"2008","unstructured":"Ciuleanu E, Irimie A, Ciuleanu TE, Popita V, Todor N, Ghilezan N. Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study. Journal of BUON: official journal of the Balkan Union of Oncology. 2008;13((1)):37\u201042.","journal-title":"Journal of BUON: official journal of the Balkan Union of Oncology"},{"issue":"3","key":"e_1_3_2_160_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/annonc\/mdq425","article-title":"Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma","volume":"22","author":"Ngeow J","year":"2011","unstructured":"Ngeow J, Lim WT, Leong SS, Ang MK, Toh CK, Gao F, et\u00a0al. Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology. 2011;22((3)):718\u201022. https:\/\/doi.org\/10.1093\/annonc\/mdq425.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"1","key":"e_1_3_2_161_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00280-007-0441-8","article-title":"Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum\u2010based chemotherapy","volume":"61","author":"Zhang L","year":"2008","unstructured":"Zhang L, Zhang Y, Huang PY, Xu F, Peng PJ, Guan ZZ. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum\u2010based chemotherapy. Cancer chemotherapy and pharmacology. 2008;61((1)):33\u20108. https:\/\/doi.org\/10.1007\/s00280\u2010007\u20100441\u20108.","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"1","key":"e_1_3_2_162_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hed.20310","article-title":"Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin\u2010resistant nasopharyngeal carcinoma","volume":"28","author":"Wang CC","year":"2006","unstructured":"Wang CC, Chang JY, Liu TW, Lin CY, Yu YC, Hong RL. Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin\u2010resistant nasopharyngeal carcinoma. Head & neck. 2006;28((1)):74\u201080. https:\/\/doi.org\/10.1002\/hed.20310.","journal-title":"Head & neck"},{"issue":"11","key":"e_1_3_2_163_2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.oraloncology.2012.05.021","article-title":"Salvage gemcitabine\u2010vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum\u2010based chemotherapy","volume":"48","author":"Chen C","year":"2012","unstructured":"Chen C, Wang FH, Wang ZQ, An X, Luo HY, Zhang L, et\u00a0al. Salvage gemcitabine\u2010vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum\u2010based chemotherapy. Oral oncology. 2012;48((11)):1146\u201051. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.05.021.","journal-title":"Oral oncology"},{"issue":"3","key":"e_1_3_2_164_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncr.20802","article-title":"Phase II study of irinotecan (CPT\u201011) as salvage therapy for advanced nasopharyngeal carcinoma","volume":"103","author":"Poon D","year":"2005","unstructured":"Poon D, Chowbay B, Cheung YB, Leong SS, Tan EH. Phase II study of irinotecan (CPT\u201011) as salvage therapy for advanced nasopharyngeal carcinoma. Cancer. 2005;103((3)):576\u201081. https:\/\/doi.org\/10.1002\/cncr.20802.","journal-title":"Cancer"},{"issue":"10","key":"e_1_3_2_165_2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","article-title":"Camrelizumab (SHR\u20101210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single\u2010arm, phase 1 trials","volume":"19","author":"Fang W","year":"2018","unstructured":"Fang W, Yang Y, Ma Y, Hong S, Lin L, He X, et\u00a0al. Camrelizumab (SHR\u20101210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single\u2010arm, phase 1 trials. The Lancet Oncology. 2018;19((10)):1338\u201050. https:\/\/doi.org\/10.1016\/s1470\u20102045(18)30495\u20109.","journal-title":"The Lancet Oncology"},{"issue":"7","key":"e_1_3_2_166_2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1200\/JCO.20.02712","article-title":"Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS\u201002)","volume":"39","author":"Wang FH","year":"2021","unstructured":"Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, et\u00a0al. Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS\u201002). Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2021;39((7)):704\u201012. https:\/\/doi.org\/10.1200\/jco.20.02712.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"14","key":"e_1_3_2_167_2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI\u20109742)","volume":"36","author":"Ma BBY","year":"2018","unstructured":"Ma BBY, Lim WT, Goh BC, Hui EP, Lo KW, Pettinger A, et\u00a0al. Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI\u20109742). Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;36((14)):1412\u20108. https:\/\/doi.org\/10.1200\/jco.2017.77.0388.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"36","key":"e_1_3_2_168_2","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1200\/JCO.2017.73.3675","article-title":"Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death\u2010Ligand 1\u2010Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE\u2010028 Study","volume":"35","author":"Hsu C","year":"2017","unstructured":"Hsu C, Lee SH, Ejadi S, Even C, Cohen RB, Le Tourneau C, et\u00a0al. Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death\u2010Ligand 1\u2010Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE\u2010028 Study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2017;35((36)):4050\u20106. https:\/\/doi.org\/10.1200\/jco.2017.73.3675.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"e_1_3_2_169_2","doi-asserted-by":"crossref","unstructured":"Zhang L Yang Y Chen X Li J Pan J He X et\u00a0al. 270MO A single\u2010arm open\u2010label multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R\/M) nasopharyngeal carcinoma (NPC) who had progressed on \u22652 lines of chemotherapy: CAPTAIN study. 2020;31.","DOI":"10.1016\/j.annonc.2020.10.264"},{"issue":"12","key":"e_1_3_2_170_2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/bjc.2017.357","article-title":"Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review","volume":"117","author":"Prawira A","year":"2017","unstructured":"Prawira A, Oosting SF, Chen TW, Delos Santos KA, Saluja R, Wang L, et\u00a0al. Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review. British journal of cancer. 2017;117((12)):1743\u201052. https:\/\/doi.org\/10.1038\/bjc.2017.357.","journal-title":"British journal of cancer"},{"issue":"10","key":"e_1_3_2_171_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00432-012-1219-x","article-title":"Comparison of five cisplatin\u2010based regimens frequently used as the first\u2010line protocols in metastatic nasopharyngeal carcinoma","volume":"138","author":"Jin Y","year":"2012","unstructured":"Jin Y, Shi YX, Cai XY, Xia XY, Cai YC, Cao Y, et\u00a0al. Comparison of five cisplatin\u2010based regimens frequently used as the first\u2010line protocols in metastatic nasopharyngeal carcinoma. Journal of cancer research and clinical oncology. 2012;138((10)):1717\u201025. https:\/\/doi.org\/10.1007\/s00432\u2010012\u20101219\u2010x.","journal-title":"Journal of cancer research and clinical oncology"},{"issue":"11","key":"e_1_3_2_172_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.21037\/atm.2018.05.14","article-title":"The efficacy of first\u2010line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta\u2010analysis","volume":"6","author":"Ma SX","year":"2018","unstructured":"Ma SX, Zhou T, Huang Y, Yang YP, Zhan JH, Zhang YX, et\u00a0al. The efficacy of first\u2010line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta\u2010analysis. Annals of translational medicine. 2018;6((11)):201. https:\/\/doi.org\/10.21037\/atm.2018.05.14.","journal-title":"Annals of translational medicine"},{"key":"e_1_3_2_173_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.oraloncology.2019.04.022","article-title":"Cost\u2010effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first\u2010line treatment of recurrent or metastatic nasopharyngeal carcinoma","volume":"94","author":"Chen X","year":"2019","unstructured":"Chen X, Liang W, Wan N, Zhang L, Yang Y, Jiang J, et\u00a0al. Cost\u2010effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first\u2010line treatment of recurrent or metastatic nasopharyngeal carcinoma. Oral oncology. 2019;94:80\u20105. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.04.022.","journal-title":"Oral oncology"},{"issue":"2","key":"e_1_3_2_174_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00280-012-2020-x","article-title":"Triplet combination with paclitaxel, cisplatin and 5\u2010FU is effective in metastatic and\/or recurrent nasopharyngeal carcinoma","volume":"71","author":"Chen C","year":"2013","unstructured":"Chen C, Wang FH, An X, Luo HY, Wang ZQ, Liang Y, et\u00a0al. Triplet combination with paclitaxel, cisplatin and 5\u2010FU is effective in metastatic and\/or recurrent nasopharyngeal carcinoma. Cancer chemotherapy and pharmacology. 2013;71((2)):371\u20108. https:\/\/doi.org\/10.1007\/s00280\u2010012\u20102020\u2010x.","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"e_1_3_2_175_2","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.2147\/CMAR.S197544","article-title":"Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives","volume":"11","author":"Lang J","year":"2019","unstructured":"Lang J, Hu C, Lu T, Pan J, Lin T. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives. Cancer management and research. 2019;11:6365\u201076. https:\/\/doi.org\/10.2147\/cmar.S197544.","journal-title":"Cancer management and research"},{"key":"e_1_3_2_176_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101890","article-title":"Management of locally recurrent nasopharyngeal carcinoma","volume":"79","author":"Lee AWM","year":"2019","unstructured":"Lee AWM, Ng WT, Chan JYW, Corry J, M\u00e4kitie A, Mendenhall WM, et\u00a0al. Management of locally recurrent nasopharyngeal carcinoma. Cancer treatment reviews. 2019;79:101890. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101890.","journal-title":"Cancer treatment reviews"},{"issue":"3","key":"e_1_3_2_177_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.radonc.2015.04.024","article-title":"Salvage endoscopic nasopharyngectomy is superior to intensity\u2010modulated radiation therapy for local recurrence of selected T1\u2010T3 nasopharyngeal carcinoma \u2013 A case\u2010matched comparison","volume":"115","author":"You R","year":"2015","unstructured":"You R, Zou X, Hua YJ, Han F, Li L, Zhao C, et\u00a0al. Salvage endoscopic nasopharyngectomy is superior to intensity\u2010modulated radiation therapy for local recurrence of selected T1\u2010T3 nasopharyngeal carcinoma \u2013 A case\u2010matched comparison. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2015;115((3)):399\u2010406. https:\/\/doi.org\/10.1016\/j.radonc.2015.04.024.","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"13","key":"e_1_3_2_178_2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ejca.2015.05.014","article-title":"New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC\/UICC rTNM classification system","volume":"51","author":"You R","year":"2015","unstructured":"You R, Zou X, Wang SL, Jiang R, Tang LQ, Zhang WD, et\u00a0al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC\/UICC rTNM classification system. European journal of cancer (Oxford, England: 1990). 2015;51((13)):1771\u20109. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.014.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"2","key":"e_1_3_2_179_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/bjc.2013.715","article-title":"Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity\u2010modulated radiotherapy","volume":"110","author":"Tian YM","year":"2014","unstructured":"Tian YM, Tian YH, Zeng L, Liu S, Guan Y, Lu TX, et\u00a0al. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity\u2010modulated radiotherapy. British journal of cancer. 2014;110((2)):297\u2010303. https:\/\/doi.org\/10.1038\/bjc.2013.715.","journal-title":"British journal of cancer"},{"issue":"3","key":"e_1_3_2_180_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1470-2045(20)30673-2","article-title":"Endoscopic surgery compared with intensity\u2010modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open\u2010label, randomised, controlled, phase 3 trial","volume":"22","author":"Liu YP","year":"2021","unstructured":"Liu YP, Wen YH, Tang J, Wei Y, You R, Zhu XL, et\u00a0al. Endoscopic surgery compared with intensity\u2010modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open\u2010label, randomised, controlled, phase 3 trial. The Lancet Oncology. 2021;22((3)):381\u201090. https:\/\/doi.org\/10.1016\/s1470\u20102045(20)30673\u20102.","journal-title":"The Lancet Oncology"},{"issue":"4","key":"e_1_3_2_181_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hed.23633","article-title":"Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma","volume":"37","author":"Chan JY","year":"2015","unstructured":"Chan JY, Tsang RK, Wei WI. Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head & neck. 2015;37((4)):487\u201092. https:\/\/doi.org\/10.1002\/hed.23633.","journal-title":"Head & neck"},{"issue":"10","key":"e_1_3_2_182_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hed.21928","article-title":"Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma","volume":"34","author":"Chen MY","year":"2012","unstructured":"Chen MY, Wang SL, Zhu YL, Shen GP, Qiu F, Luo DH, et\u00a0al. Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head & neck. 2012;34((10)):1383\u20108. https:\/\/doi.org\/10.1002\/hed.21928.","journal-title":"Head & neck"},{"issue":"8","key":"e_1_3_2_183_2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hed.23719","article-title":"Salvage endoscopic nasopharyngectomy and intensity\u2010modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma","volume":"37","author":"Zou X","year":"2015","unstructured":"Zou X, Han F, Ma WJ, Deng MQ, Jiang R, Guo L, et\u00a0al. Salvage endoscopic nasopharyngectomy and intensity\u2010modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma. Head & neck. 2015;37((8)):1108\u201015. https:\/\/doi.org\/10.1002\/hed.23719.","journal-title":"Head & neck"},{"issue":"5","key":"e_1_3_2_184_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hed.20161","article-title":"Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group","volume":"27","author":"Yu KH","year":"2005","unstructured":"Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, et\u00a0al. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head & neck. 2005;27((5)):397\u2010405. https:\/\/doi.org\/10.1002\/hed.20161.","journal-title":"Head & neck"},{"issue":"2","key":"e_1_3_2_185_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/lary.27317","article-title":"Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection","volume":"129","author":"Liu YP","year":"2019","unstructured":"Liu YP, Li H, You R, Li JB, Liu XK, Yang AK, et\u00a0al. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection. The Laryngoscope. 2019;129((2)):387\u201095. https:\/\/doi.org\/10.1002\/lary.27317.","journal-title":"The Laryngoscope"},{"issue":"9","key":"e_1_3_2_186_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2017.75.5165","article-title":"Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy","volume":"36","author":"Li YQ","year":"2018","unstructured":"Li YQ, Tian YM, Tan SH, Liu MZ, Kusumawidjaja G, Ong EHW, et\u00a0al. Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;36((9)):891\u20109. https:\/\/doi.org\/10.1200\/jco.2017.75.5165.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"e_1_3_2_187_2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ijrobp.2011.07.006","article-title":"Intensity\u2010modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma","volume":"83","author":"Qiu S","year":"2012","unstructured":"Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ. Intensity\u2010modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. International journal of radiation oncology, biology, physics. 2012;83((2)):676\u201083. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.07.006.","journal-title":"International journal of radiation oncology"},{"issue":"10","key":"e_1_3_2_188_2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/00005537-200210000-00033","article-title":"Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors","volume":"112","author":"To EW","year":"2002","unstructured":"To EW, Lai EC, Cheng JH, Pang PC, Williams MD, Teo PM. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors. The Laryngoscope. 2002;112((10)):1877\u201082. https:\/\/doi.org\/10.1097\/00005537\u2010200210000\u201000033.","journal-title":"The Laryngoscope"},{"issue":"4","key":"e_1_3_2_189_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00016480701813806","article-title":"Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors","volume":"128","author":"Hao SP","year":"2008","unstructured":"Hao SP, Tsang NM, Chang KP, Hsu YS, Chen CK, Fang KH. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors. Acta oto\u2010laryngologica. 2008;128((4)):473\u201081. https:\/\/doi.org\/10.1080\/00016480701813806.","journal-title":"Acta oto\u2010laryngologica"},{"issue":"4","key":"e_1_3_2_190_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO\u2010EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow\u2010up(\u2020)","volume":"32","author":"Bossi P","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et\u00a0al. Nasopharyngeal carcinoma: ESMO\u2010EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow\u2010up(\u2020). Annals of oncology: official journal of the European Society for Medical Oncology. 2021;32((4)):452\u201065. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.007.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"1","key":"e_1_3_2_191_2","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1038\/s41467-020-17672-w","article-title":"An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk\u2010based approach","volume":"11","author":"Zhou GQ","year":"2020","unstructured":"Zhou GQ, Wu CF, Deng B, Gao TS, Lv JW, Lin L, et\u00a0al. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk\u2010based approach. Nature communications. 2020;11((1)):3872. https:\/\/doi.org\/10.1038\/s41467\u2010020\u201017672\u2010w.","journal-title":"Nature communications"},{"issue":"4","key":"e_1_3_2_192_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ijrobp.2018.01.117","article-title":"Cost\u2010Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow\u2010Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy","volume":"102","author":"Zhou GQ","year":"2018","unstructured":"Zhou GQ, Wu CF, Zhang J, Mao YP, Tang LL, Chen L, et\u00a0al. Cost\u2010Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow\u2010Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy. International journal of radiation oncology, biology, physics. 2018;102((4)):1382\u201091. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.117.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"e_1_3_2_193_2","doi-asserted-by":"crossref","unstructured":"Huang XD Zhou GQ Lv JW Zhou HQ Zhong CW Wu CF et\u00a0al. Competing risk nomograms for nasopharyngeal carcinoma in the intensity\u2010modulated radiotherapy era: A big\u2010data intelligence platform\u2010based analysis. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2018;129(2):389\u201095. https:\/\/doi.org\/10.1016\/j.radonc.2018.09.004.","DOI":"10.1016\/j.radonc.2018.09.004"},{"issue":"17","key":"e_1_3_2_194_2","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","article-title":"Intensity\u2010modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two\u2010dimensional radiotherapy: A 10\u2010year experience with a large cohort and long follow\u2010up","volume":"51","author":"Zhang MX","year":"2015","unstructured":"Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, et\u00a0al. Intensity\u2010modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two\u2010dimensional radiotherapy: A 10\u2010year experience with a large cohort and long follow\u2010up. European journal of cancer (Oxford, England: 1990). 2015;51((17)):2587\u201095. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.006.","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"21","key":"e_1_3_2_195_2","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1002\/cncr.30850","article-title":"A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10\u2010year outcomes for efficacy and toxicity","volume":"123","author":"Lee AWM","year":"2017","unstructured":"Lee AWM, Tung SY, Ng WT, Lee V, Ngan RKC, Choi HCW, et\u00a0al. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10\u2010year outcomes for efficacy and toxicity. Cancer. 2017;123((21)):4147\u201057. https:\/\/doi.org\/10.1002\/cncr.30850.","journal-title":"Cancer"},{"key":"e_1_3_2_196_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.03.015","article-title":"Ten\u2010year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity\u2010modulated radiotherapy: An analysis of 614 patients from a single center","volume":"69","author":"Wu LR","year":"2017","unstructured":"Wu LR, Liu YT, Jiang N, Fan YX, Wen J, Huang SF, et\u00a0al. Ten\u2010year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity\u2010modulated radiotherapy: An analysis of 614 patients from a single center. Oral oncology. 2017;69:26\u201032. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.03.015.","journal-title":"Oral oncology"},{"key":"e_1_3_2_197_2","unstructured":"Pfister DG Spencer S Adelstein D et\u00a0al. Nccn clinical practice guidelines in oncology: Head and neck cancers. Version 1.2021. Accessed nov 12 2020. To view the most recent version visit nccn.Org."},{"key":"e_1_3_2_198_2","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-9-87","article-title":"Local failure patterns for patients with nasopharyngeal carcinoma after intensity\u2010modulated radiotherapy","volume":"9","author":"Li JX","year":"2014","unstructured":"Li JX, Huang SM, Jiang XH, Ouyang B, Han F, Liu S, et\u00a0al. Local failure patterns for patients with nasopharyngeal carcinoma after intensity\u2010modulated radiotherapy. Radiation oncology (London, England). 2014;9:87. https:\/\/doi.org\/10.1186\/1748\u2010717x\u20109\u201087.","journal-title":"Radiation oncology (London, England)"},{"issue":"4","key":"e_1_3_2_199_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/RMR.0b013e3181572b3a","article-title":"Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow\u2010up","volume":"18","author":"Glastonbury CM","year":"2007","unstructured":"Glastonbury CM. Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow\u2010up. Topics in magnetic resonance imaging: TMRI. 2007;18((4)):225\u201035. https:\/\/doi.org\/10.1097\/RMR.0b013e3181572b3a.","journal-title":"Topics in magnetic resonance imaging: TMRI"},{"key":"e_1_3_2_200_2","doi-asserted-by":"crossref","unstructured":"Yu E O'Sullivan B Kim J Siu L Bartlett E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert review of anticancer therapy. 2010;10(3):365\u201075. https:\/\/doi.org\/10.1586\/era.10.9.","DOI":"10.1586\/era.10.9"},{"issue":"1","key":"e_1_3_2_201_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40880-016-0167-2","article-title":"Prognostic factors and failure patterns in non\u2010metastatic nasopharyngeal carcinoma after intensity\u2010modulated radiotherapy","volume":"35","author":"Mao YP","year":"2016","unstructured":"Mao YP, Tang LL, Chen L, Sun Y, Qi ZY, Zhou GQ, et\u00a0al. Prognostic factors and failure patterns in non\u2010metastatic nasopharyngeal carcinoma after intensity\u2010modulated radiotherapy. Chinese journal of cancer. 2016;35((1)):103. https:\/\/doi.org\/10.1186\/s40880\u2010016\u20100167\u20102.","journal-title":"Chinese journal of cancer"},{"issue":"52","key":"e_1_3_2_202_2","doi-asserted-by":"crossref","first-page":"86914","DOI":"10.18632\/oncotarget.13564","article-title":"Investigation of long\u2010term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity\u2010modulated radiotherapy: a retrospective analysis","volume":"7","author":"Zhao W","year":"2016","unstructured":"Zhao W, Lei H, Zhu X, Li L, Qu S, Liang X. Investigation of long\u2010term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity\u2010modulated radiotherapy: a retrospective analysis. Oncotarget. 2016;7((52)):86914\u201025. https:\/\/doi.org\/10.18632\/oncotarget.13564.","journal-title":"Oncotarget"},{"issue":"6","key":"e_1_3_2_203_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.oraloncology.2013.02.006","article-title":"Clinical scenario of EBV DNA follow\u2010up in patients of treated localized nasopharyngeal carcinoma","volume":"49","author":"Hsu CL","year":"2013","unstructured":"Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, et\u00a0al. Clinical scenario of EBV DNA follow\u2010up in patients of treated localized nasopharyngeal carcinoma. Oral oncology. 2013;49((6)):620\u20105. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.02.006.","journal-title":"Oral oncology"},{"issue":"19","key":"e_1_3_2_204_2","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1002\/cncr.26069","article-title":"Plasma Epstein\u2010Barr virus DNA screening followed by \u00b9\u2078F\u2010fluoro\u20102\u2010deoxy\u2010D\u2010glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma","volume":"117","author":"Wang WY","year":"2011","unstructured":"Wang WY, Twu CW, Lin WY, Jiang RS, Liang KL, Chen KW, et\u00a0al. Plasma Epstein\u2010Barr virus DNA screening followed by \u00b9\u2078F\u2010fluoro\u20102\u2010deoxy\u2010D\u2010glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma. Cancer. 2011;117((19)):4452\u20109. https:\/\/doi.org\/10.1002\/cncr.26069.","journal-title":"Cancer"},{"issue":"1","key":"e_1_3_2_205_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40880-017-0256-x","article-title":"Prognostic value of plasma Epstein\u2010Barr virus DNA level during posttreatment follow\u2010up in the patients with nasopharyngeal carcinoma having undergone intensity\u2010modulated radiotherapy","volume":"36","author":"Li WF","year":"2017","unstructured":"Li WF, Zhang Y, Huang XB, Du XJ, Tang LL, Chen L, et\u00a0al. Prognostic value of plasma Epstein\u2010Barr virus DNA level during posttreatment follow\u2010up in the patients with nasopharyngeal carcinoma having undergone intensity\u2010modulated radiotherapy. Chinese journal of cancer. 2017;36((1)):87. https:\/\/doi.org\/10.1186\/s40880\u2010017\u20100256\u2010x.","journal-title":"Chinese journal of cancer"},{"issue":"7","key":"e_1_3_2_206_2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.20129","article-title":"Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein\u2010Barr virus DNA","volume":"100","author":"Hong RL","year":"2004","unstructured":"Hong RL, Lin CY, Ting LL, Ko JY, Hsu MM. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein\u2010Barr virus DNA. Cancer. 2004;100((7)):1429\u201037. https:\/\/doi.org\/10.1002\/cncr.20129.","journal-title":"Cancer"},{"issue":"3","key":"e_1_3_2_207_2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4143\/crt.2018.298","article-title":"Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big\u2010Data Intelligence Platform\u2010Based Analysis of 6,377 Long\u2010term Survivors from an Endemic Area Treated with Intensity\u2010Modulated Radiation Therapy during 2003\u20102013","volume":"51","author":"Zhang LL","year":"2019","unstructured":"Zhang LL, Li GH, Li YY, Qi ZY, Lin AH, Sun Y. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big\u2010Data Intelligence Platform\u2010Based Analysis of 6,377 Long\u2010term Survivors from an Endemic Area Treated with Intensity\u2010Modulated Radiation Therapy during 2003\u20102013. Cancer research and treatment. 2019;51((3)):982\u201091. https:\/\/doi.org\/10.4143\/crt.2018.298.","journal-title":"Cancer research and treatment"}],"container-title":["Cancer Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cac2.12218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cac2.12218","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1002\/cac2.12218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:55:18Z","timestamp":1773824118000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1002\/cac2.12218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":206,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1002\/cac2.12218"],"URL":"https:\/\/doi.org\/10.1002\/cac2.12218","relation":{},"ISSN":["2523-3548"],"issn-type":[{"value":"2523-3548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"2021-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}